key: cord-0028439-l7xlqbhf
authors: Fang, Mingqian; Tang, Xiaopeng; Zhang, Juan; Liao, Zhiyi; Wang, Gan; Cheng, Ruomei; Zhang, Zhiye; Zhao, Hongwen; Wang, Jing; Tan, Zhaoxia; Kamau, Peter Muiruri; Lu, Qiumin; Liu, Qi; Deng, Guohong; Lai, Ren
title: An inhibitor of leukotriene-A(4) hydrolase from bat salivary glands facilitates virus infection
date: 2022-03-01
journal: Proc Natl Acad Sci U S A
DOI: 10.1073/pnas.2110647119
sha: 1f264b1f1f5e0a6b78474ee797c5bc265b0d1ccf
doc_id: 28439
cord_uid: l7xlqbhf

Bats are increasingly accepted as potential reservoirs of many viruses that cause zoonotic disease outbreaks through spillover to other animals and humans. However, our understanding of the factors that contribute to virus spillover from bats is very limited. Here, we identified and characterized an immunosuppressant protein (MTX) that is highly concentrated in the submandibular salivary gland of the bat, Myotis pilosus. By selectively inhibiting the epoxide hydrolase function of leukotriene-A(4) hydrolase (LTA(4)H) to inhibit LTA(4) hydrolysis and the generation of leukotriene B(4) (LTB(4)), a potent lipid chemoattractant for host defense against infection, MTX inhibited the antiviral responses of the host and facilitated viral infection. MTX had no effect on the aminopeptidase function of LTA(4)H and therefore did not impair the antiinflammatory function of LTA(4)H. MTX potently inhibited proinflammatory proteases (i.e., plasmin, trypsin, and elastase) to induce immune tolerance and maintain high stability. In mouse models, influenza A virus (IAV) H1N1 infection and pathogenicity were exacerbated by MTX but were reversed by interfering with the effects of MTX on LTA(4)H or exogenous LTB(4) administration. This study provides deeper insight into immunologically privileged sites for microbial community residence in bats and supports the therapeutic potential of targeting MTX-LTA(4)H.

Bats are increasingly accepted as potential reservoirs of many viruses that cause zoonotic disease outbreaks through spillover to other animals and humans. However, our understanding of the factors that contribute to virus spillover from bats is very limited. Here, we identified and characterized an immunosuppressant protein (MTX) that is highly concentrated in the submandibular salivary gland of the bat, Myotis pilosus. By selectively inhibiting the epoxide hydrolase function of leukotriene-A 4 hydrolase (LTA 4 H) to inhibit LTA 4 hydrolysis and the generation of leukotriene B 4 (LTB 4 ), a potent lipid chemoattractant for host defense against infection, MTX inhibited the antiviral responses of the host and facilitated viral infection. MTX had no effect on the aminopeptidase function of LTA 4 H and therefore did not impair the antiinflammatory function of LTA 4 H. MTX potently inhibited proinflammatory proteases (i.e., plasmin, trypsin, and elastase) to induce immune tolerance and maintain high stability. In mouse models, influenza A virus (IAV) H1N1 infection and pathogenicity were exacerbated by MTX but were reversed by interfering with the effects of MTX on LTA 4 H or exogenous LTB 4 administration. This study provides deeper insight into immunologically privileged sites for microbial community residence in bats and supports the therapeutic potential of targeting MTX-LTA 4 

Myotis pilosus j salivary gland j toxin j immunosuppressive j virus transmission C ertain high-impact zoonotic disease outbreaks have been linked to bat-borne viruses, including severe acute respiratory syndrome coronavirus (SARS-CoV), rabies virus, influenza virus, Hendra and Nipah viruses, Ebola and Marburg hemorrhagic fever filoviruses, Middle East respiratory syndrome (MERS) coronavirus, and most recently, SARS-CoV-2 (1-3). Bats are increasingly being considered as potential reservoirs harboring a diverse and complex microbial community, including many known and unknown viruses (4) (5) (6) (7) (8) (9) (10) (11) . More than 15 families of zoonotic viruses have been identified in >200 species of bats worldwide (4) (5) (6) (7) (8) (9) (10) (11) , many of which can spill over into animal and human populations and cause diseases. Thus, there may be immunologically privileged sites for microbial community residence and/or factors contributing to bat-borne pathogen spillover. However, information on bat biology and immunology remains insufficient to clarify the generation of immunological privilege and immune tolerance. Furthermore, studies on the factors contributing to the risk of bat pathogen spillover and crossspecies transmission are limited.

Pathogen infection events in bat tissue also remain poorly understood, although virus-host interactions between the Egyptian fruit bat (Rousettus aegyptiacus) and Marburg virus provide strong evidence of viral shedding through oral secretions, indicating a viable route for horizontal infection (12) . Thus, we speculate that host factors related to the oral cavities of bats may facilitate virus residence and invasion. As a ubiquitously expressed proinflammatory epoxide hydrolase, leukotriene A 4 hydrolase (LTA 4 H) bears two opposing roles, i.e., proinflammation by producing leukotriene B 4 (LTB 4 ) and antiinflammation (13, 14) . LTB 4 is a potent chemoattractant, which acts primarily on neutrophils, eosinophils, T cells, and mast cells (15) (16) (17) . LTB 4 exerts its biological functions via two types of G protein-coupled receptors (GPCRs): i.e., LTB 4 receptors 1 and 2 (BLT1/2) (18, 19) . Produced by its rate-limiting enzyme LTA 4 H, LTB 4 activates the extracellular signal-regulated kinase (ERK), protein kinase B (AKT), and nuclear factor-κB (NF-κB) subunit p65 signaling pathway through BLT; licenses Significance An immunosuppressant protein (MTX), which facilitates virus infection by inhibiting leukotriene A 4 hydrolase (LTA 4 H) to produce the lipid chemoattractant leukotriene B 4 (LTB 4 ), was identified and characterized from the submandibular salivary glands of the bat Myotis pilosus. To the best of our knowledge, this is a report of an endogenous LTA 4 H inhibitor in animals. MTX was highly concentrated in the bat salivary glands, suggesting a mechanism for the generation of immunological privilege and immune tolerance and providing evidence of viral shedding through oral secretions. Moreover, given that the immunosuppressant MTX selectively inhibited the proinflammatory activity of LTA 4 H, without affecting its antiinflammatory activity, MTX might be a potential candidate for the development of antiinflammatory drugs by targeting the LTA 4 -LTA 4 H-LTB 4 inflammatory axis. inflammasome activation; increases the expression of the Toll/Interleukin 1 receptor (TIR) adaptor MyD88 and the transcription factors NF-κB, activator protein-1 (AP-1), and purine rich box-1 (PU.1); and promotes the production of proinflammatory factors, leading to an inflammatory response in the host, which intensifies the production of LTA 4 H and LTB 4 and activates the antiviral immune system (20) (21) (22) (23) (24) (25) . In this work, we identified and characterized a LTA 4 H inhibitor (MTX) from the submandibular salivary glands (also known as "submaxillary" glands) of the bat Myotis pilosus at a high concentration (∼1% of total protein) and explored its effects on host immunity and virus invasion. By targeting LTA 4 H with high affinity to inhibit the production of the proinflammatory mediator LTB 4 , MTX effectively inhibited proinflammatory functions and antiviral immunity of the host to facilitate virus infection.

Inhibitor of LTA 4 H. We purified and characterized a protein with a molecular weight of 13 kDa from the salivary glands of M. pilosus. This protein (MTX) inhibited the activity of several proinflammatory enzymes, including plasmin (inhibitory constant K i = 79.99 nM), trypsin (K i = 67.51 nM), and elastase (K i = 35.94 nM), and showed a half-life of 16 h in mouse plasma ( Fig. 1 A and B and SI Appendix, Fig. S1 ). The cDNA encoding the MTX precursor (SI Appendix, Fig. S1E ) of 135 amino acid (aa) residues, including an 18-aa predicted signal peptide, and mature MTX was cloned. BLAST searching showed that MTX was a double-knot Kazal-type serine protease inhibitor. Immunoblot analysis and enzyme-linked immunosorbent assay (ELISA) indicated that MTX was distributed in the submaxillary salivary glands at a high concentration (∼1% of total protein, 7 to 10 μg/mg), but was not found in other tissues at significant concentrations (Fig. 1A) . We expressed and purified MTX (SI Appendix, Fig. S2 ) to analyze its enzyme inhibitory activity and function in vitro and in vivo. Based on the coimmunoprecipitation analysis, MTX directly interacted with LTA 4 H (SI Appendix, Fig. S3 ), as confirmed by surface plasmon resonance (SPR) (Fig. 1C ) and native-polyacrylamide gel electrophoresis (PAGE) analyses (Fig. 1D ). SPR analysis revealed that the equilibrium dissociation constant (KD) for the interaction between MTX and LTA 4 H was 0.45 nM, thus showing a high affinity. MTX selectively inhibited the epoxide hydrolase function of LTA 4 H (K i : 1.23 μM) to inhibit leukotriene A 4 (LTA 4 ) hydrolysis and block the generation of leukotriene B 4 (LTB 4 ) (Fig. 1 E-G) . However, MTX did not affect the aminopeptidase function of LTA 4 H (SI Appendix, Fig. S4A ) and therefore did not impair its antiinflammatory function. In addition, MTX had no effect on phospholipase A2 (PLA2), cytochrome p450 (CYP450), and total cyclooxygenase (COX) enzyme activities (SI Appendix, Fig. S4 B, C and D) in vitro.

LTA 4 H Is Elevated in Response to H1N1 Infection. LTA 4 H plays a key role in catalyzing the final and rate-limiting step of LTB 4 biosynthesis, which has been implicated in many acute and chronic inflammatory diseases (13, 14, (26) (27) (28) (29) . Significantly elevated plasma concentrations of LTA 4 H and LTB 4 were observed in the H1N1-infected mouse model ( Fig. 1 H and I) , suggesting that the increase in LTB 4 production following LTA 4 H upregulation is an antiviral response of the host.

MTX Augments H1N1 Infection by Inhibiting Inflammatory Axis LTA 4 -LTA 4 H-LTB 4 . As a key factor in eicosanoid storms caused by infection, LTA 4 H is a potent contributor to inflammation (13) . Furthermore, eicosanoid storms are associated with the occurrence of cytokine storms (30, 31) . Given the potent ability of MTX to inhibit LTA 4 H, we tested its effects on the inflammatory axis LTA 4 -LTA 4 H-LTB 4 and cytokine production induced by viral infection (Fig. 2 A and B and SI Appendix, Figs. S5 A and D-I and S6). Following H1N1 infection, LTA 4 H, inflammatory mediator LTB 4 (derived from LTA 4 hydrolysis by LTA 4 H), proinflammatory cytokines interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α) and interleukin 1β (IL-1β), and inflammatory cell chemokine interleukin 8 (IL-8) were significantly elevated in all tested cells (i.e., nonsmall cell lung cancer [NSCLC] line A549 cells ( Fig. 2 A and B and SI Appendix, Fig. S6E ), human lung fibroblast cell line Medical Research Council 5 (MRC-5) cells (SI Appendix, Fig. S6 B, D, G), plasmacytoid dendritic cells (pDCs) (SI Appendix, Fig. S6 A, C, and H), and human umbilical vein endothelial cells (HUVECs) (SI Appendix, Figs. S5 A and D-I and S6F). In contrast, these elevations were inhibited by administration of MTX or antibodies against BLT1/2 (0.5 μg/mL of anti-BLT1 antibody mixed with 0.5 μg/mL of anti-BLT2 antibody). In addition, MTX also reduced the production of prostaglandin E 2 (PGE 2 ) and cysteinyl leukotrienes (CysLTs) induced by H1N1 in A549 cells ( Fig. 2 B, iii and iv). LTA 4 H is up-regulated during inflammation (32) (33) (34) (35) . Here, as illustrated in Fig. 2 A, ii, and B, i, both MTX and anti-BLT1/2 treatment inhibited the elevation of LTA 4 H induced by H1N1 infection, which was likely due to the inhibition of inflammation. The antiinflammatory activity of MTX and anti-BLT1/2 impaired the antiviral ability of the cells and augmented H1N1 infection, as observed by the increase in virus nucleoprotein (NP) (H1N1 PR8 NP) expression and virus titer ( Fig. 2A ).

MTX inhibited LTB 4 production by inhibiting LTA 4 H, suggesting that it may also inhibit LTB 4 receptor signaling. The activation of various inflammatory signaling pathway proteins, i.e., ERK, AKT, and NF-κB subunit p65, is related to LTB 4 and BLT (20) (21) (22) (23) (24) (25) . As illustrated in Fig. 2 C, i and SI Appendix, Neutrophil chemotaxis can be promoted by LTB 4 and chemokines and plays an important role in antiviral immunity in hosts (36) . Given the inhibitory activity of MTX on the LTA 4 -LTA 4 H-LTB 4 axis inflammation, we tested its effects on neutrophil chemotaxis in cell coculture systems of A549-polymorphonuclear neutrophils (PMNs) (Fig. 3) and HUVECs-PMNs (SI Appendix, Fig. S9 ). H1N1 infection promoted neutrophil chemotaxis and activation, as indicated by the up-regulation of myeloperoxidase (MPO) expression of PMNs on the A549 cells and HUVECs ( Fig. 3 A and B and SI Appendix, Fig. S9A ). However, MTX and anti-BLT1/2 antibodies inhibited neutrophil activation, as indicated by the down-regulation of MPO expression (Fig. 3 A and B and SI Appendix, Fig. S9A ) and elevation of viral load (NP expression, Fig. 3 A and G and SI Appendix, Fig. S9 A and E) and viral titers in the cells (Fig. 3F) . Notably, 2 μM MTX and anti-BLT1/2 antibody treatment nearly completely inhibited neutrophil activation. As expected, MTX and anti-BLT1/2 antibodies in the cell coculture systems inhibited LTA 4 H, LTB 4 , and IL-8 production ( Fig. 3 C-E and SI Appendix, Fig. S9 B-D) . (Fig. 4E) . The formation of neutrophil extracellular traps (NETs) was also inhibited (SI Appendix, Fig. S10 A and B) . The concentrations of LTB 4 , IL-6, IL-1β, TNF-α, and CXCL1 and gene expression levels of IL-6, IL-1β, TNF-α, and CXCL1 were much lower in the lung tissues of LTA 4 H À/À mice infected with the H1N1 virus than in that of WT mice (Fig. 4 E-I) . Lipidomic analysis also showed the down-regulation of LTB 4 and prostaglandins (PGs) in the MTX-treated group after H1N1 infection (SI Appendix, Fig.  S10D) . A large number of cytokines (i.e., IL-1β, IL-6, and TNF-α) are known to enhance PGE 2 production by affecting PLA2 and COX (37) (38) (39) (40) . Although MTX had no effect on PLA2 and COX enzyme activities in vitro, MTX may have reduced the production of PGs (SI Appendix, Fig. S10D ) through reduced inflammation in vivo. Moreover, in mice, exogenous administration of LTB 4 may also increased the content of PGE 2 by increasing lung cytokines (SI Appendix, Fig.  S11 D-F) . Upon H1N1 infection, the chemotaxis and activation of neutrophils, eosinophils, DCs, CD16 + CD3 À natural killer (NK) cells, and CD8 + T cells in the lungs of WT mice were significantly stimulated. However, MTX, anti-BLT1/2, and LTA 4 H knockout suppressed chemotaxis and activation of these cells (Fig. 4 J-N and SI Appendix, Fig. S12 ). These results suggest that MTX plays an immunosuppressive role by inhibiting LTA 4 H.

After 9 d of H1N1 infection, compared with low virus NP expression in the lungs and livers of WT mice, immunofluorescence indicated high NP expression in LTA 4 H À/À mice and in mice administered either MTX or anti-BLT1/2 antibodies (Fig. 5A ). In addition, TdT-mediated dUTP nick-end labeling Quantification of signaling intensity of p-ERK (ii) and p-AKT (iii) using GAPDH as the loading control, and quantification of p65 (iv) signaling intensity using histone as the loading control (blots in SI Appendix, Fig. S2A ). (D) LTB 4 activated the downstream inflammatory signaling pathway of BLT1 to inhibit viral infection. A549 cells treated with U75302 (BLT1 antagonist, 100 nM), MTX (2 μM), or LTB 4 in the presence or absence of H1N1 virus. After 1 h, we detected activation of signaling pathway proteins p65, ERK, and AKT and their phosphorylation by immunoblot analysis (blots in SI Appendix, Fig. S2B ). After 24 h of virus infection in each treatment group, IAV titer and NP gene expression were detected by TCID 50 and qRT-PCR, respectively (E). Each symbol (A, iii and iv; B; C, ii-iv; D; and E) indicates an individual technical replicate in one experiment, and small horizontal (A, iii and iv; B; C, ii-iv; D; and E) lines indicate mean ± SEM. Data are representative of (A, i and ii; and C, i) and are from (A, iii and iv; B; C, ii-iv; D; and E) three independent experiments. *P < 0.05, **P < 0.01 by one-way ANOVA with Fisher's protected t tests.

(TUNEL) staining showed a much lower number of apoptotic cells in the lungs and livers of WT mice infected with H1N1 than in the LTA 4 H À/À , MTX, and anti-BLT1/2 mice (Fig. 5A ). Hematoxylin and eosin (H&E) staining indicated that tissue injuries, including cell deformation (thickened alveoli septum in lungs) and inflammatory infiltration, were more severe in the LTA 4 H À/À , MTX, and anti-BLT1/2 mice than in the WT mice (Fig. 5A ). In addition, at 9 d after infection, the serum H1N1 virus titer in the LTA 4 H À/À , MTX, and anti-BLT1/2 mice was much higher than that in the WT mice (Fig. 5 B, i) . qRT-PCR also revealed that viral replication in the brain, kidney, lung, and liver was much higher in the LTA 4 H À/À , MTX, and anti-BLT1/2 mice than in the WT mice at day 9 after infection ( Fig. 5 B, ii-v) . Viral load in the lungs of the LTA 4 H À/À , MTX, and anti-BLT1/2 mice was much higher than that in the WT mice on days 1, 3, and 9 after infection (Fig. 5C ). After 6 to 14 d of virus infection, body weight decreased significantly in the LTA 4 H À/À , MTX, and anti-BLT1/2 mice compared with that observed in the WT mice (Fig. 5D) .

LTB 4 Administration Inhibits Viral Infection. Significant reductions in LTB 4 (Fig. 4E) were observed in the LTA 4 H À/À , MTX, and anti-BLT1/2 mice, which were associated with severe virus infection ( Fig. 4 A-C) and low inflammatory response (Fig. 4  F-N) , suggesting that inhibition of the LTA 4 -LTA 4 H-LTB 4 inflammatory axis promoted viral infection, and using exogenous LTB 4 administration to block LTA 4 -LTA 4 H-LTB 4 inhibition elicited by LTA 4 H À/À or MTX likely inhibited viral infection. As shown in Fig. 5 E-G, the exogenous addition of LTB 4 (inoculated intranasally with 50 ng LTB 4 per mouse) reversed the increase in H1N1 infection in MTX-treated mice and LTA 4 À/À mice. In addition, MTX inhibition of the LTA 4 -LTA 4 H-LTB 4 inflammatory axis was blocked by MTX antibody, exogenous LTB 4 , and peptide KLVVDLTDIDPDVA (IM14, for MTX-LTA 4 H interaction interference) administration (a designed peptide, SI Appendix, Fig. S13 ) (intravenous injection of LTB 4 0.1 mg/kg, MTX antibody 0.25 mg/kg, or IM14 2 mg/kg), which interfered with the effects of MTX on LTA 4 H. Their effects on H1N1 infection were evaluated. As expected, the viral load in the lung was inhibited by exogenous LTB 4 , MTX antibody, and IM14 administration (SI Appendix, Fig. S11 A and B) . The interferences also inhibited the decrease in body weight caused by viral infection from days 6 to 14 (SI Appendix, Fig.  S11C ). Administration of MTX alone exacerbated H1N1 infection and pathological injury, while LTB 4 , MTX antibody, and IM14 treatment significantly alleviated infection and injury (SI Appendix, Fig. S11A ). Moreover, exogenous administration of LTB 4 increased the levels of IL-6, TNF-α, and PGE 2 in mice lungs (SI Appendix, Fig. S11 D-F) , further demonstrates the immune defense effect of LTB 4 and its induction of cytokine production, as reported previously (20) (21) (22) (23) (24) (25) . The COX inhibitor piroxicam was administered to eliminate the influence of PGE 2 and PGD 2 on the MTX-LTB 4 pathway during viral infection. As illustrated in SI Appendix, Fig. S11 G-I, piroxicam had no effect on the increase in viral infection elicited by MTX, further indicating the immunosuppressive effect of MTX. 

Salivary glands have been described as a test bed for new and adaptive roles of secretory proteins (41) (42) (43) . Although there are ∼1,100 species of bats worldwide, constituting 23% of all mammalian species, only salivary gland proteins associated with hematophagous behavior in vampire bats (three species) have been intensively studied (44) (45) (46) (47) (48) (49) (50) (51) (52) . Although several viruses have been identified from bats, the crucial factors that profoundly contribute to the modification of host immune response and pathogen spillover are not yet known. In this study, from the bat salivary gland of M. pilosus, we identified and characterized a inhibitor (MTX) of LTA 4 H, a potent inflammatory driver. Given its high concentration in the bat salivary glands (7 to 10 μg/mg tissue) and high inhibitory activity against host immunity, MTX possibly creates an immunologically privileged environment and induces host immune tolerance to resident microorganisms in bat oral cavities by counteracting the LTB 4 -mediated host immune response. Based on its physiological concentration in the bat, MTX administration facilitated H1N1 infection and enhanced H1N1 invasion into a mammalian host by antagonizing the host immune response.

Leukotrienes contribute to antiinfective inflammatory responses (53) (54) (55) . LTB 4 is an inflammatory lipid mediator and is implicated in many acute and chronic inflammatory diseases (14, 26, 56) . LTA 4 H is a ubiquitously expressed proinflammatory epoxide hydrolase bearing two opposing roles in immune regulation, including inflammation promotion by catalyzing the conversion of LTA 4 to the inflammatory mediator LTB 4 and antiinflammation by inactivating and degrading the chemotactic tripeptide Pro-Gly-Pro (13, 14) . LTA 4 H represents an attractive target for the design of superior antiinflammatory drugs as it triggers the final critical and rate-limiting step for LTB 4 biosynthesis (13) . Previously, no LTA 4 H endogenous inhibitor has been identified in animals. In the current study, we showed that MTX from the bat salivary gland selectively inhibited the epoxide hydrolase function of LTA 4 H and suppressed LTA 4 hydrolysis to block LTB 4 generation. However, MTX did not affect the aminopeptidase activity of LTA 4 H, and thus did not impair its antiinflammatory function.

As shown in Fig. 4 , LTA 4 H À/À mice exhibited decreased cytokine expression and escalated viral infection processes following H1N1 infection, which may be the result of decreased LTB 4 production (57, 58) . LTB 4 is one of the most potent known chemoattractant, acting on neutrophils, eosinophils, T cells, and mast cells (15) (16) (17) . LTB 4 causes neutrophil chemotaxis, and NETs formed by neutrophils show strong antibacterial properties and play a key role in antiviral immunity by oxidative bursts and phagocytosis (36) . In the current study, the immunosuppressive protein MTX inhibited the chemotaxis of neutrophils and the occurrence of cytokine storm by inhibiting the production of the chemokine LTB 4 , and thus promoted viral invasion. Cytokine storms induced by influenza A virus (IAV) can promote the up-regulation of LTA 4 H (32-35), which further increases LTB 4 production, BLT inflammatory signaling pathway activation, inflammatory factor release, and immune defense function. Due to its selective inhibition of the hydrolysis of LTA 4 by LTA 4 H into LTB 4 without affecting the aminopeptidase activity and antiinflammatory function of LTA 4 H in hosts, MTX likely facilitates virus infection. As illustrated in Fig. 5 and SI Appendix, Fig. S11 , the administration of exogenous LTB 4 , MTX antibodies, or IM14 significantly inhibited viral infection and thus alleviated pathological injuries and inflammatory infiltration, while the sympotms were more severe in LTA 4 H À/À animals that lack LTB 4 . In addition to its direct inflammatory effects on viral infection inhibition, LTB 4 may also contribute to the alleviation of pathological injuries by activating the LTB 4 -BLT1/2 pathway to decrease cAMP generation and regulating the cross-talk between PGE 2 , IL-1β, and LTB 4 to control inflammation and tissue injury, as reported recently (39, 40) .

Trypsin-like proteases participate in inflammatory responses by activating protease-activated receptor 2 (59, 60) . Neutrophil elastases are associated with neutrophil-mediated inflammation by regulating the functions of neutrophils as immune response triggers (61, 62) . As a key protease related to the fibrinolytic system, plasmin also participates in proinflammatory processes (63) (64) (65) (66) (67) . Here, MTX potently inhibited proinflammatory proteases (K i of ∼10 À9 M) such as plasmin, trypsin, and elastase, which likely strengthened its immunosuppressive functions. In addition, the ability of MTX to inhibit multiple proteases may contribute to its high stability (plasma half-life of 16 h in vivo). These features of MTX (i.e., potent inhibitory effects on LTA 4 H and multiple proteases, high stability in vivo, and high concentration in the salivary gland) may endow it with superior strength to inhibit host immunity, create immunologically privileged sites, induce immune tolerance, and facilitate pathogen cross-species invasion. As illustrated in SI Appendix, Fig. S14 , virus infection stimulated LTA 4 H-dominant inflammatory responses, while MTX facilitated H1N1 infection and exacerbated pathogenicity.

Given the critical role of LTA 4 H in the biosynthesis of LTB 4 , an inflammatory mediator (26, 56) , LTA 4 H inhibition is suggested as a potent strategy for the development of antiinflammatory drugs. At present, however, very few candidates targeting LTA 4 H have shown clinical efficacy due to their limited selectivity (13) . In this report, MTX was identified as an endogenous LTA 4 H inhibitor from an animal. Without affecting the aminopeptidase function of LTA 4 H, MTX selectively inhibited the activity of epoxide hydrolase, providing a candidate and/or template for the development of superior and safe antiinflammatory drugs.

Ethics Statement. All experimental procedures involving animals were approved by the Institutional Animal Care and Use Committees at the Kunming Institute of Zoology, Chinese Academy of Sciences (approval ID: SMKX-20191015-33). All possible efforts were made to reduce sample size and minimize animal suffering. Human blood samples were collected according to the clinical protocols approved by the Institutional Review Board of the Kunming Institute of Zoology (approval ID: SMKX-20191101-197). All human blood samples were collected with informed consent.

Purification and Feature Analysis of MTX. MTX was purified from the bat salivary gland of M. pilosus by a Sephadex 200 Increase 10/300 gel filtration combined with resource Q anion exchange and subjected to partial amino acid sequencing by automated Edman degradation. Its cDNA (accession No.: BankIt2509688) was cloned from the cDNA library of the salivary gland using degenerate primers according to the amino acid sequence. The effects of MTX on LTA 4 H were studied by coimmunoprecipitation, SPR, native polyacrylamide gel electrophoresis, protein-protein docking, reverse-phase high-performance liquid chromatography combined with ELISA and mass spectrometry. Its effects on enzymatic functions of serine proteases, PLA2, COX1/2, and CYP450, were studied using chromogenic assays and enzyme activity assay kits. Detailed steps are described in SI Appendix.

Effects of MTX on LTB 4 Receptor Signaling, Immunity, and H1N1 Infection. The in vitro effects of MTX on LTB 4 receptor signaling, immunity, and H1N1 infection in HUVECs, pDCs, A549 cells, and MRC-5 cells were evaluated using qRT-PCR, Western blot, ELISA, and immunofluorescence analyses to detect LTA 4 H, cytokines, NP, BLT1, AKT, ERK, p65, and virus titer. Fiveweek-old WT and LTA 4 H À/À C57BL/6J male mice were used to study the in vivo effects of MTX on immunity and infection through the above techniques combined with H&E and TUNEL staining to detect inflammation, H1N1 virus titer, and histopathological injury. Further details are available in SI Appendix.

Novel coronavirus disease (COVID-19): A pandemic (epidemiology, pathogenesis and potential therapeutics)

A tale of two viruses: The distinct spike glycoproteins of feline coronaviruses

Six reference-quality genomes reveal evolution of bat adaptations

Fruit bats as reservoirs of Ebola virus

A comparison of bats and rodents as reservoirs of zoonotic viruses: Are bats special?

Isolation of genetically diverse Marburg viruses from Egyptian fruit bats

Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect

Bats host major mammalian paramyxoviruses

Isolation of Hendra virus from pteropid bats: A natural reservoir of Hendra virus

Mass extinctions, biodiversity and mitochondrial function: Are bats 'special' as reservoirs for emerging viruses?

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus)

Eicosanoid storm in infection and inflammation

Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors

The role of leukotriene B(4) in allergic diseases

Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis

BLT2, a leukotriene B4 receptor 2, as a novel prognostic biomarker of triple-negative breast cancer

Biological functions of 12(S)-hydroxyheptadecatrienoic acid as a ligand of leukotriene B4 receptor 2

Role of leukotriene B 4 receptor-2 in mast cells in allergic airway inflammation

Leukotriene B4 licenses inflammasome activation to enhance skin host defense

Leukotriene B(4) enhances tumour necrosis factor-alphainduced CCL27 production in human keratinocytes

Mechanisms regulating skin immunity and inflammation

Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression

Leukotriene B4 enhances the generation of proinflammatory micro-RNAs to promote MyD88-dependent macrophage activation

Macrophage dectin-1 expression is controlled by leukotriene B4 via a GM-CSF/PU.1 axis

The leukotrienes: Immune-modulating lipid mediators of disease

Haeggstr€ om, Targeting leukotriene B4 in inflammation

Haeggstr€ om, Leukotriene A4 hydrolase and the committed step in leukotriene B4 biosynthesis

Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis

Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor

Rapid induction of inflammatory lipid mediators by the inflammasome in vivo

Lipopolysaccharide and cytokines modulate leukotriene (LT)B4 and LTC4 production by porcine endometrial endothelial cells

The role of the LTB4-BLT1 axis in health and disease

Bestatin cream impairs solar simulated light-driven skin inflammation and skin carcinogenesis in mice

Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension

Interplay between neutrophils, NETs and T-cells in SARS-CoV-2 infection-A missing piece of the puzzle in the COVID-19 pathogenesis?

Lipid mediator class switching during acute inflammation: Signals in resolution

The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease

Interleukin-1 receptor-induced PGE2 production controls acetylcholine-mediated cardiac dysfunction and mortality during scorpion envenomation

Opposing roles of LTB4 and PGE2 in regulating the inflammasomedependent scorpion venom-induced mortality

Contributions in Mammalogy; A Volume Honoring Professor E. Raymond Hall, University of Kansas Museum of Natural History Miscellaneous publication

Dietary and flight energetic adaptations in a salivary gland transcriptome of an insectivorous bat

Salivary glands, cellular evolution, and adaptive radiation in mammals

Purification and partial characterization of draculin, the anticoagulant factor present in the saliva of vampire bats (Desmodus rotundus)

The plasminogen activator of vampire bat saliva

Plasminogen activator in saliva of the vampire bat Desmodus rotundus

Inhibitor of platelet aggregation present in saliva of the vampire bat Desmodus rotundus

Draculin, the anticoagulant factor in vampire bat saliva, is a tight-binding, noncompetitive inhibitor of activated factor X

Isolation, characterization, and cDNA cloning of a vampire bat salivary plasminogen activator

The "Vampirome": Transcriptome and proteome analysis of the principal and accessory submaxillary glands of the vampire bat Desmodus rotundus, a vector of human rabies

The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: Cloning and expression

Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo

Nasal lavage leukotrienes in infants with RSV bronchiolitis

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitis

Leukotriene B4 release from mast cells in IgE-mediated airway hyperresponsiveness and inflammation

The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans

Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants

Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism

Early immunologic events at the tick-host interface

Transcriptional profiling of the murine cutaneous response during initial and subsequent infestations with Ixodes scapularis nymphs

The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways

Plasmin triggers cytokine induction in human monocyte-derived macrophages

Plasmin triggers chemotaxis of monocyte-derived dendritic cells through an Akt2-dependent pathway and promotes a T-helper type-1 response

The serine protease plasmin triggers expression of the CC-chemokine ligand 20 in dendritic cells via Akt/NF-kappa B-dependent pathways

Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway

Data Availability. All study data are included in the article and SI Appendix.ACKNOWLEDGMENTS. This work was supported by the National Key R&D Program of China (2018YFA0801403), the Chongqing Natural Science Foundation (cstc2019jcyj-zdxmX0004), the National Natural Science Foundation of China (31930015, 32100907, and 81930061), the Chinese Academy of Sciences (XDB31000000, SAJC202103, KFJ-BRP-008-003), the Chongqing Municipal Education Commission (HZ2021020), the KC Wong Education Foundation, and the Science and Technology Department of Yunnan Province (202003AD150008, 2019ZF003, 2019-YT-053, 2019FI014, and 202002AA100007).